课题基金 / 基金详情

Role of cystatin in stimulation of saliva flow and protection of oral mucosa

Role of cystatin in stimulation of saliva flow and protection of oral mucosa
半胱氨酸蛋白酶抑制剂在刺激唾液流动和保护口腔粘膜中的作用
批准号:
23592948
负责人:
NAKAGAWA Yoichi
金额:
$3.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

NAKAGAWA Yoichi的其他基金

相似基金

相关文献

中文摘要
翻译
半胱氨酸蛋白酶抑制剂是半胱氨酸蛋白酶抑制剂家族。半胱氨酸蛋白酶抑制剂被认为在细胞凋亡中具有重要作用。干燥综合征患者唾液胱抑素减少,尤其是胱抑素S。在正常对照组的唇唾液腺中,观察到Cystatin的强染色,但在Sjogren综合征患者中有很少的阳性例子,并且染色极低。这些结果表明,胱抑素参与调节干燥综合征的发病。
英文摘要
The cystatins are a family of cysteine protease inhibitors. Cysteine protease inhibitors are assumed to have important roles in apoptosis. Salivary cystatin decreased in Sjogren's syndrome patients, particularly cystatin S. In the labial salivary glands, intense staining of the cystatin was observed in the normal control group, but there were few positive examples in Sjogren's syndrome patients, and the staining was extremely low. These results suggest that the cystatin participates in the regulation of onset of Sjogren's syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research about one nation's role, orientation and international cooperation under the global society
  • 批准号:
    26780108
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.41万
  • 财政年份:
    2014
  • 负责人:
    NAKAGAWA Yoichi
  • 依托单位:
Management of dry mouth ; Influence of mucin on oral dryness
  • 批准号:
    20592348
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.58万
  • 财政年份:
    2008
  • 负责人:
    NAKAGAWA Yoichi
  • 依托单位:
Inhibition of parasympathetic saliva flow by sympathetic nerve stimulation
  • 批准号:
    17592116
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.33万
  • 财政年份:
    2005
  • 负责人:
    NAKAGAWA Yoichi
  • 依托单位:
Alteration of salivary IgA level due to surgical stress
  • 批准号:
    14571921
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.79万
  • 财政年份:
    2002
  • 负责人:
    NAKAGAWA Yoichi
  • 依托单位:
海外基金